Target intelligence / Profile preview

Ribosomal protein L11 pseudogene 3 (RPL11P3)

Target
RPL11P3
Molecular classification
Other (Pseudogene; does not belong to canonical families such as receptors, enzymes, or transporters)
01

Overview

Ribosomal protein L11 pseudogene 3 (RPL11P3) is a processed pseudogene related to the ribosomal protein L11 gene (RPL11). Pseudogenes are nonfunctional sequences in the genome formed by duplication or retrotransposition from functional genes. Unlike its parent gene, RPL11, which encodes a structural component of the 60S ribosomal subunit and has well-characterized biological functions and disease associations (such as Diamond-Blackfan anemia), RPL11P3 does not produce a functional protein and has no confirmed biological or therapeutic role. While some pseudogenes have regulatory activity or are transcribed as noncoding RNAs, there is no reported evidence that RPL11P3 plays such a role. It primarily serves as a genomic fossil and is studied mainly in comparative genomics and evolutionary biology. Key differences: - RPL11P3 (the pseudogene) should not be confused with RPL11, the ribosomal protein, which is essential for ribosome function and has medically relevant roles. - The presence of RPL11P3 in the genome does not confer any known disease risks or drug interactions. Summary: RPL11P3 is a nonfunctional pseudogene derived from the ribosomal protein L11 gene. It is not a drug target and has no clinical, biomarker, or disease relevance in current biomedical literature.

Other names
RPL11P3RPL11_2_1077Ribosomal protein L11 pseudogene 3
02

Biological functions

Other (Most pseudogenes are nonfunctional. However, a small number can act as regulatory elements—for example, as noncoding RNAs influencing gene expression—but no evidence supports such a role for RPL11P3 specifically.)
03

Disease associations

Other (No known disease roles. The parent gene, RPL11, is associated with Diamond-Blackfan anemia and potentially cancer, but the pseudogene has no established disease associations.)

Beyond the preview

Go deeper on Ribosomal protein L11 pseudogene 3 (RPL11P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L11 pseudogene 3 (RPL11P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call